Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-02T23:26:10.149Z Has data issue: false hasContentIssue false

34 - Brain microvessel antigens

from Part IV - Signal transduction/biochemical aspects

Published online by Cambridge University Press:  10 December 2009

William M. Pardridge
Affiliation:
University of California, Los Angeles, School of Medicine
Get access

Summary

Introduction

Understanding the structure–function relationship of the BBB depends on the identification of the molecular components involved. One approach to address this topic is based on the generation of monospecific antibodies starting typically from heterogeneous immunogen fractions. The resulting antibodies are then used to identify the corresponding antigens and determine their function, therefore following a structure-to-function strategy. This chapter is focused on antigens of this experimental history, whereas antibodies for characterized vascular endothelial proteins such as glucose transporters, transferrin-and VEGF receptors, junction proteins etc. will be discussed elsewhere. Besides being helpful to reveal the molecular architecture of the BBB, antigens could be employed as diagnostic indexes to evaluate BBB integrity under pathological conditions in vivo or, for example, as differentiation markers in in vitro models.

HT7/Neurothelin

One of the most thoroughly studied antigens present on brain micro vessels is HT7/neurothelin. In two independent approaches using as immunogens either tissue homogenates or purified cell membranes of the embryonic chicken retina, monoclonal antibodies (MAb) HT7 and 1W5 were generated. The corresponding antigens, which have subsequently been shown to be identical, have been termed HT7 (Risau et al., 1986) and neurothelin (Schlosshauer and Herzog, 1990), respectively. As deduced from cDNA sequencing, the antigen has 246 amino acids with a predicted molecular weight of 26 893 daltons.

Type
Chapter
Information
Introduction to the Blood-Brain Barrier
Methodology, Biology and Pathology
, pp. 314 - 321
Publisher: Cambridge University Press
Print publication year: 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×